Chlorambucil in Indolent Chronic Lymphocytic Leukemia

Chlorambucil in Indolent Chronic Lymphocytic Leukemia

To determine whether chlorambucil treatment benefits patients with indolent chronic lymphocytic leukemia (CLL), we conducted two randomized trials in 1535 patients with previously untreated stage A CLL.

Saved in:
书目详细资料
Main Authors: Guillaume Dighiero, Karim Maloum, B Desablens, Bruno Cazin, Maurice Navarro, R Leblay, M Leporrier, J. Jaubert, G. Lepeu, Brigitte Dreyfus, Jacques‐Louis Binet, Philippe Travade, François-Louis Turpin, G. Tertian, Agnès Bichoffe
格式: Artigo
语言:英语
出版: 1998
在线阅读:https://doi.org/10.1056/nejm199805213382104
https://www.nejm.org/doi/pdf/10.1056/NEJM199805213382104?articleTools=true
标签: 添加标签
没有标签, 成为第一个标记此记录!

因特网

https://doi.org/10.1056/nejm199805213382104
https://www.nejm.org/doi/pdf/10.1056/NEJM199805213382104?articleTools=true

相似书籍